OncoSec Medical Inc (ONCSQ)

[lasers]

It not a case of ethics it is a case of 1st publisher acceptance. $ONCS has put a ton of work and $mil into their Melanoma Clinical trials. The Window of opportunity was only a few weeks wide between ASCO and ASGCT . To only submit to one when the deadlines were only a few weeks apart was to drastically limit the possibilities of prestigious Peer Review publication.

The other question to ask is why wouldn't they have sent their premier Melanoma P1/2 abstract to ASCO.


As I said waiting for $ONCS to clarify the situation.